OBJECTIVES: To investigate the pathophysiological role of adrenomedullin in myocardial infarction. PATIENTS AND DESIGN: Plasma concentrations of adrenomedullin, atrial natriuretic factor, and brain natriuretic peptide were measured by radioimmunoassay in 31 patients with acute myocardial infarction over four weeks, and in 44 normal subjects. RESULTS: In patients with acute myocardial infarction, plasma adrenomedullin reached a peak of (mean (SD) 14.0 (9.0) pmol/l at 24 hours after the onset of symptoms and remained increased at all sampling points except the four week point compared with the value in normal subjects (5.0 (2.0) pmol/l). Adrenomedullin concentrations on admission were higher in patients from Killip class II, III, and IV than class I, and correlated positively with peak plasma creatine kinase and left ventricular end diastolic volume index, and negatively with left ventricular ejection fraction. The values from 12 to 48 hours were negatively correlated with systemic vascular resistance index. During the time course studied, adrenomedullin concentrations were positively correlated with atrial natriuretic factor (r = 0.40, p < 0.001) and brain natriuretic peptide (r = 0.53, p < 0.001). CONCLUSIONS: Plasma adrenomedullin concentrations increased in the acute phase of myocardial infarction in proportion with clinical severity suggesting that adrenomedullin may play an important role in the pathophysiology of myocardial infarction.
OBJECTIVES: To investigate the pathophysiological role of adrenomedullin in myocardial infarction. PATIENTS AND DESIGN: Plasma concentrations of adrenomedullin, atrial natriuretic factor, and brain natriuretic peptide were measured by radioimmunoassay in 31 patients with acute myocardial infarction over four weeks, and in 44 normal subjects. RESULTS: In patients with acute myocardial infarction, plasma adrenomedullin reached a peak of (mean (SD) 14.0 (9.0) pmol/l at 24 hours after the onset of symptoms and remained increased at all sampling points except the four week point compared with the value in normal subjects (5.0 (2.0) pmol/l). Adrenomedullin concentrations on admission were higher in patients from Killip class II, III, and IV than class I, and correlated positively with peak plasma creatine kinase and left ventricular end diastolic volume index, and negatively with left ventricular ejection fraction. The values from 12 to 48 hours were negatively correlated with systemic vascular resistance index. During the time course studied, adrenomedullin concentrations were positively correlated with atrial natriuretic factor (r = 0.40, p < 0.001) and brain natriuretic peptide (r = 0.53, p < 0.001). CONCLUSIONS: Plasma adrenomedullin concentrations increased in the acute phase of myocardial infarction in proportion with clinical severity suggesting that adrenomedullin may play an important role in the pathophysiology of myocardial infarction.
Authors: C M Wei; D M Heublein; M A Perrella; A Lerman; R J Rodeheffer; C G McGregor; W D Edwards; H V Schaff; J C Burnett Journal: Circulation Date: 1993-09 Impact factor: 29.690
Authors: E Morita; H Yasue; M Yoshimura; H Ogawa; M Jougasaki; T Matsumura; M Mukoyama; K Nakao Journal: Circulation Date: 1993-07 Impact factor: 29.690
Authors: K Kitamura; K Kangawa; M Kawamoto; Y Ichiki; S Nakamura; H Matsuo; T Eto Journal: Biochem Biophys Res Commun Date: 1993-04-30 Impact factor: 3.575
Authors: K Kitamura; Y Ichiki; M Tanaka; M Kawamoto; J Emura; S Sakakibara; K Kangawa; H Matsuo; T Eto Journal: FEBS Lett Date: 1994-03-21 Impact factor: 4.124
Authors: S Eguchi; Y Hirata; H Kano; K Sato; Y Watanabe; T X Watanabe; K Nakajima; S Sakakibara; F Marumo Journal: FEBS Lett Date: 1994-03-07 Impact factor: 4.124
Authors: N Nagaya; T Nishikimi; M Uematsu; Y Yoshitomi; Y Miyao; S Miyazaki; Y Goto; S Kojima; M Kuramochi; H Matsuo; K Kangawa; H Nonogi Journal: Heart Date: 1999-05 Impact factor: 5.994
Authors: Naureen Javeed; Gunisha Sagar; Shamit K Dutta; Thomas C Smyrk; Julie S Lau; Santanu Bhattacharya; Mark Truty; Gloria M Petersen; Randal J Kaufman; Suresh T Chari; Debabrata Mukhopadhyay Journal: Clin Cancer Res Date: 2014-10-29 Impact factor: 12.531
Authors: K Watanabe; T Nishikimi; M Takamuro; K Yasuda; Y Ishikawa; S Tanabe; O Yamada; N Nagaya; H Matsuoka; K Kangawa; S Echigo Journal: Pediatr Cardiol Date: 2003-09-04 Impact factor: 1.655
Authors: Svenja Hinrichs; Katharina Scherschel; Saskia Krüger; Johannes Tobias Neumann; Michael Schwarzl; Isabell Yan; Svenja Warnke; Francisco M Ojeda; Tanja Zeller; Mahir Karakas; Till Keller; Christian Meyer; Stefan Blankenberg; Dirk Westermann; Diana Lindner Journal: Proc Natl Acad Sci U S A Date: 2018-08-30 Impact factor: 11.205